Chairman Gerd Weithase Leads Flavine Expansion

May 5, 2006 (Press Release) -- Munich, Germany -- April 25th, 2006 -- Flavine is currently expanding its international operations on a wide scale. Chairman Gerd Weithase is instigating this development from Flavine’s European main office in Munich, Germany and is also personally at the forefront of exploring the potential of the Chinese, Japanese and Indian markets. As the catalyst of Flavine’s expansion, Gerd Weithase has been the driving force behind the improved customer relationships and the establishment of new partners and links which have been instrumental in Flavine’s continued international success. A bridge to API’s indeed.

Flavine, represented by Chairman Gerd Weithase, is a marketing and distributing company for FDA approved active pharmaceutical ingredients and intermediates for the human and health industries. Flavine has actively linked advanced API manufacturers with markets and pharmaceutical companies since 1975. With marketing and regulatory operations in today’s important international locations of North America, Europe and Asia, Flavine will continue to play a leading role in the selection of quality API manufacturers. Meeting the requirements of its demanding FDA approved customers in the increasingly stringent quality and regulatory environment is Flavine’s major assignment to its motivated and experienced international team.